Wyden: HHS Violated Non-Interference Clause In Negotiations With Pfizer

July 12, 2018
The top Senate Finance Committee Democrat says the Trump administration violated the non-interference clause by pressuring Pfizer to reverse course on price hikes for more than 40 drugs. Policy watchers have questioned whether multiple parts of HHS' drug pricing plan could run afoul of the provision, which prohibits the government from getting involved in negotiations involving drug makers, Part D plans and pharmacies, and congressional appropriators appear concerned. Pfizer announced Tuesday (July 10) it had abandoned planned drug price hikes...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.